Emphysema Chronic obstructive Pulmonary Disease

A group of lung diseases that block airflow and make it difficult to breathe

Treatments: Treatment consists of self care and bronchodilators. Rescue inhalers or oral steroids can help control symptoms and minimize further damage

Emphysema and chronic bronchitis are the most common conditions that make up COPD. Damage to the lungs from COPD can't be reversed. Symptoms include shortness of breath, wheezing, or a chronic cough.

Ages of Humans most likely to be affected by Emphysema

People may experience:

Cough: can be dry or with phlegm

Respiratory: frequent respiratory infections, shortness of breath, or

wheezing

Whole body: fatigue or inability to exercise

Also common: chest tightness

Self-care

Physical exercise: Aerobic activity for 20-30 minutes 5 days a week improves cardiovascular health. If injured, pursuing an activity that avoids the injured muscle group or joint can help maintain physical function while recovering.

Smoking cessation: Quitting smoking tobacco.

Causes: Smoking or inhaling other unhealthy substances. Doing this sort of thing is definitely one of the main causes of this disease.

Anatomical: Inside the respiratory system when Emphysema occurs, the tar build-up inside of your lungs gets blocked from the smoking, making it difficult to breath, especially after forms of exercises.

Prevention: One way to prevent Emphysema is to quit smoking. Another thing that might help prevent it is to wear a gas when working with chemicals and other various substances.

Overview: Emphysema is a long term progressive disease of the lungs, which can result in many adverse symptoms, limiting your ability to do everyday tasks. There is not currently a cure but you can have treatment that may be able to help you.

Made with Adobe Slate

Make your words and images move.

Get Slate

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.